Brought to you by 
Senseonics nets $23.5mm via FOPO
22 Jul 2019
Executive Summary
Senseonics Holdings Inc. (developing an implantable continuous glucose monitoring (CGM) system) netted $23.5mm through the public sale of 22.7mm common shares at $1.10. The company concurrently announced an $80mm debt financing.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
In Vitro Diagnostics
- Biosensors
- Glucose Testing
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Senseonics nets $23.5mm via FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice